The time course of left ventricular (LV) function was compared in normal (N) and cardiac-denervated (CD) dogs over an 8-week period after instrumentation with solid-state LV pressure gauges and three pairs of ultrasonic crystals to measure LV long and short axes and wall thickness. Baseline LV systolic, end-systolic, and end-diastolic pressures did not differ in N and CD dogs. Heart rate was higher (p<0.01) and LV dP/dt was lower (p<0.05) in CD dogs. LV short-axis shortening, shortening fraction, velocity of circumferential fiber shortening, and ejection fraction were consistently lower (p<0.01) in CD dogs. With angiotensin II to increase LV afterload, relations of LV short-axis shortening, shortening fraction, velocity of circumferential fiber shortening, and ejection fraction to average LV systolic wall stress were shifted downward (p<O.O1) in CD dogs at 2, 4, and 8 weeks. Relations of LV short-axis shortening to LV end-diastolic wall stress also diflered (p<0.01) in N and CD dogs. Ganglionic blockade abolished differences in LV function between N and CD dogs during elevated LV systolic wall stress with angiotensin II. Thus, in conscious dogs, cardiac denervation results in a sustained reduction of LV function over a wide range of ventricular loading conditions. (Circulation Research 1992;71:365-375) KEY WoRDs * cardiac denervation * left ventricular function * left ventricular afterload * angiotensin II
In conscious dogs, left ventricular (LV) systolic pressure, LV end-diastolic pressure, LV dP/dt, and cardiac output are not generally altered after cardiac denervation. [1] [2] [3] [4] [5] [6] [7] [8] This suggests that a lack of neural input to the heart has little influence on LV function. Regarding regional LV function, both reductions in function and no change have been reported after cardiac denervation. Jones et a13 found an early reduction of segmental LV wall shortening followed by a gradual recovery over an 8-week period. In contrast, Shen et al8 demonstrated that baseline ventricular wall thickening in dogs with cardiac denervation (CD) was stable over an 8-week period and did not differ from that of normal (N) dogs. In the study by Amano et al, 4 LV segmental wall motion did not differ in N and CD dogs 2-4 weeks after surgery. For overall LV function, Stinson et a19 reported a reduced baseline short-axis shortening fraction 10 days to 4 weeks after cardiac denervation. To our knowledge, no data are available on the time course of overall LV function after cardiac denervation in relation to ventricular loading conditions. Therefore, the primary goal of the present study was to compare sequentially, at 2, 4, and 8 weeks, baseline LV function in N and CD dogs. We also examined the consequences of increasing LV systolic wall stress on LV function. Finally, we considered that any difference in LV function between N and CD dogs should be abolished after ganglionic blockade.
Materials and Methods
Under general anesthesia with sodium pentobarbital (30 mg/kg i.v.) and under sterile conditions, seven mongrel dogs (23±1 kg) underwent a left thoracotomy at the fifth intercostal space under artificial ventilation. The pericardium was widely incised parallel to the phrenic nerve. Through an apical stab wound, a solidstate pressure transducer (model P6.5, Konigsberg Instruments, Pasadena, Calif.) was implanted in the LV cavity to record LV systolic pressure and LV end-diastolic pressure and to obtain the first derivative of LV pressure, LV dP/dt. A Tygon (Norton Plastics and Synthetic Division, Akron, Ohio) catheter was also implanted in the ventricular cavity to cross-calibrate the miniature pressure gauge. Throughout these experiments, the stability of the transducer was verified against measurements of the LV systolic and diastolic pressures with the chronically implanted catheter. Therefore, any drift of the instrument could be detected and eliminated by these repeated calibrations. A catheter was also implanted in the thoracic aorta to monitor systolic aortic pressure. LV and aortic pressures were recorded using pressure transducers (model 800, Bent- ley Trantec, Irvine, Calif.) connected to the catheters. Ultrasonic (3-MHz) piezoelectric crystals of 5 mm diameter were inserted into the LV cavity through the epicardium and positioned on anterior and posterior LV endocardial surfaces, 2-3 cm under the atrioventricular ring and adjacent to the interventricular septum. These crystals were connected to an ultrasonic sonomicrometer (model 120, Triton Technology, San Diego, Calif.) to record instantaneous LV dimensions. This instrument monitors the transit time of acoustic signals traveling at constant sonic velocity between the piezoelectric transducers. LV long-axis diameter was monitored using a hemispheric 3-MHz crystal (6 mm) implanted on the apical endocardium and a crystal positioned at the basal epicardial surface, in the groove between the left atrium and the aortic root. A pair of 7-MHz crystals, with one crystal implanted in the endocardium of the LV free wall and the other at the epicardial surface, was used to monitor LV wall thickness on the same plane where LV short-axis measurements were made. Adequate acoustic alignment of the transducers was confirmed during surgery by determining the position of the epicardial crystal where wall thickness was the smallest. The pericardium was left open, the chest was closed in layers, and the catheters and wires were exteriorized on the back of the animals.
The same instrumentation was implanted in another group of eight dogs (23±1 kg) after an intrapericardial cardiac denervation according to the technique described by Randall et al,10 which has been demonstrated to reduce ventricular catecholamine content by more than 98%.2 In brief, this procedure consists of 1) sectioning of the ventrolateral cardiac nerve, 2) adventitial stripping of the left pulmonary veins and the right and common pulmonary arteries, and 3) sectioning of pericardial reflections in the transverse sinus and around the superior vena cava as well as ligation and sectioning of the azygos vein. In addition, anterior and posterior ansae subclaviae were bilaterally transected extrapericardially. In these animals, a catheter was also implanted in the left atrium. Adequacy of cardiac denervation was confirmed in conscious animals, 2-3 days before performing the experimental protocols, by demonstrating the failure of heart rate and LV dP/dt to change after intravenous bolus administration of pressor doses of nitroglycerin (15.0 ,ug/kg) and phenylephrine (3.0 gg/kg). Absence of decreases in heart rate and mean arterial pressure after intra-atrially administered veratrine (8.0 ,ug/kg) confirmed elimination of afferent cardiac nerves. The same procedure was repeated near the completion of the experiments, at 8 weeks after cardiac denervation.
Heart rate was obtained with a cardiotachometer (model 9857, Sensor Medics, Anaheim, Calif.) triggered by the LV pressure pulse. Hemodynamics and dimensions were continuously recorded on an eight-channel tape recorder (model 3968A, Hewlett-Packard Co., San Diego, Calif.) and monitored on a direct ink-writing strip-chart recorder (model 2800s, Gould, Cleveland, Ohio).
Protocols
Experiments were initiated 2 weeks after surgery in conscious healthy dogs lying quietly on their right sides in a dimly illuminated laboratory. While LV systolic pressure, LV end-diastolic pressure, LV dP/dt, phasic aortic pressure, longand short-axis dimensions, wall thickness, and heart rate were continuously monitored, a steady-state baseline was obtained followed by the intravenous administration of angiotensin II (Sigma Chemical Co., St. Louis, Mo.). Doses of angiotensin II were selected in the range of 0.1-1.6 ,ug/min to elevate peak LV systolic pressure by successive steps corre-sponding to 140, 160, and 180 mm Hg. Each pressure step was obtained by adjusting the delivery of angiotensin II and was maintained for 2-3 minutes until a steady-state level was reached. This method of increasing LV afterload was selected because angiotensin II within this dose range lacks significant inotropic effect on the LV.11-13 This protocol was performed at 2, 4, and 8 weeks after instrumentation in N and CD dogs. At 4 and 8 weeks, angiotensin II was also administered after ganglionic blockade with intravenous hexamethonium bromide (40 mg/kg) and methyl atropine (0.1 mg/kg) in N and CD conscious dogs. Adequacy of ganglionic blockade was confirmed in N dogs by demonstrating the absence of changes in heart rate and LV dP/dt after intravenous bolus administration of pressor doses of phenylephrine (3.0 ,ug/kg) and nitroglycerin (10.0 gg/ kg). At the completion of the experiments, the animals were killed with an overdose of sodium pentobarbital followed by potassium chloride. The heart was excised, and appropriate transducer placement was verified. The heart was sectioned at the atrioventricular junction and trimmed of all adherent tissue; then the weight of the LV (septum plus free wall) was obtained.
Data Analysis
After the completion of each experiment, LV pressure, longand short-axis dimensions, and wall thickness analog signals were digitized every 2.5 msec on a computer-assisted system (AT compatible) and analyzed with software developed in our laboratory. LV dimensions and pressure were read at end diastole, i.e., immediately before the rapid rise of LV pressure, and at end systole, i.e., 20 msec before peak negative LV dP/dt obtained with a numerical differentiator. Ejection time was taken as the interval between peak positive LV dP/dt and 20 msec before peak negative LV dP/dt. Cavity volume was calculated with an ellipsoidal model14: EDV=(IT/6)(EDD)2(EDL-0.55 xEDW) and ESV=(w/6)(ESD)2(ESL-0.55 x ESW)
where EDV is end-diastolic volume, EDD is endocardial end-diastolic short axis, EDL is end-diastolic long axis, EDW is end-diastolic wall thickness, ESV is endsystolic volume, ESD is endocardial end-systolic short axis, ESL is end-systolic long axis, and ESW is endsystolic wall thickness. Note that 0.55 of wall thickness is subtracted from the measured long axis because one of the long-axis crystals is endocardial and the second is epicardial. Shortening fraction (SF), a percent change of LV short axis, was calculated using
SF= [(EDD-ESD)/EDD] x 100%
A similar approach was used to calculate long-axis SF and wall thickening fraction.
Ejection fraction (EF) was calculated similarly using EF=[(EDV-ESV)/EDV] x 100%
Mean velocity of circumferential fiber shortening (Vcf) was calculated as follows15:
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Vcf=[(EDD -ESD)/EDD]/ETx RR where ET is ejection time (in seconds) and RR is the RR interval (in seconds).
Instantaneous LV circumferential wall stress (o-, in grams per square centimeter) was calculated from the digital data using an ellipsoidal model13:
where LVP is LV pressure, SAX is the short axis, WTH is wall thickness, and LAX is the long axis minus 0.55WTH. Average LV systolic wall stress (bf) was obtained by the integration of the stress-time curve from peak positive LV dP/dt (tl) to 20 msec before peak negative LV dP/dt (t2) divided by ET U= | ( dt/ET tl All values are reported as mean±SEM. Comparisons of baseline within groups over time were performed with a one-way analysis of variance with repeated measurements followed by Bonferroni's t test to isolate specific contrasts.'6 Simultaneous comparisons between groups over time under baseline conditions or under various levels of LV pressure at a given time point were performed using a two-way analysis of variance with repeated measurements16 followed by Scheffe's F test'7 to examine specific contrasts. An analysis of covariance was performed for overall comparisons of variables reported as a function of either average LV systolic wall stress or end-diastolic LV wall stress in N and CD dogs. 16 Differences were considered statistically significant atp<0.05.
All experimental procedures were approved by an ethics committee on animal care and performed in accordance with "Guide to the Care and Use of Experimental Animals" (Canadian Council on Animal Care publication No. [ISBN] 0-909187- 10-8, Ottawa, 1980 10-8, Ottawa, -1984 .
Results
Experiments were initiated in seven N dogs and in eight CD dogs and completed in all dogs over the 8-week period. LV weights were similar in N (117±4 g) and CD (105±7 g) dogs. LV/body weight ratios were similar in N (4.86±0.11) and CD (4.61±0.26) dogs. Measurements of hemodynamics and LV function were made in all normal dogs; however, LV dP/dt was not available in one dog at 8 weeks. LV long-axis dimensions were not measured in two CD dogs. Consequently, LV volumes and stresses are reported in six CD dogs.
Other variables were obtained in all animals. For reasons of clarity in the data presentation and because responses to angiotensin II were similar at 2, 4, and 8 weeks, hemodynamic effects of angiotensin II were reported only at 4 weeks. Baseline LV systolic function and hemodynamics under baseline conditions are reported in Table 1 . Except for a significant decrease of LV dP/dt at 8 weeks in N dogs, all hemodynamic and LV function variables remained sta-ble throughout the duration of the experiments in both groups. Consistent differences between N and CD dogs were apparent over the period of investigation. LV short-axis shortening and shortening fraction, Vcf, and ejection fraction ( Figure 1 ) were significantly lower in CD dogs at all times. Heart rate was higher in CD than N dogs at all times. LV dP/dt and ejection time differed in N and CD dogs, but statistical significance was not reached at all times. Peak LV systolic and end-systolic pressures, LV long-axis shortening and shortening fraction, LV wall thickening and thickening fraction, and average LV systolic wall stress did not differ in N and CD dogs. Baseline LV end-diastolic hemodynamics and dimensions are reported in Table 2 . Over 8 weeks, end-diastolic variables remained stable in N and CD dogs.
Angiotensin II
The hemodynamic effects of the highest dose of angiotensin II that raised peak LV systolic pressure up to 180 mm Hg in N and CD dogs are reported in Figure  2 . Peak LV systolic and end-systolic pressures, LV end-diastolic pressure, and stroke volume reached similar levels in N and CD dogs under angiotensin II. Heart rate failed to change from baseline in both groups and remained higher in CD dogs. LV dP/dt fell slightly but similarly in N and CD dogs and remained lower in CD dogs. Figure 3 summarizes the relations of LV short-axis shortening and shortening fraction, Vcf, and ejection fraction to average LV systolic wall stress during angiotensin II administration in N and CD dogs at 2 weeks. For increases of average LV systolic wall stress within the same range in both groups, CD dogs consistently demonstrated a parallel shift in LV systolic function to lower levels, as determined with analysis of covariance. Similar relations between indexes of LV systolic function and average LV systolic wall stress were found at 4 weeks ( Figure 4 ) and 8 weeks ( Figure 5 ). Figure 6 summarizes the relation of LV short-axis shortening to LV end-diastolic wall stress at 2, 4, and 8 weeks. For levels of LV end-diastolic wall stress within the same range, CD dogs demonstrated a downward shift of these relations.
Ganglionic Blockade
Baseline LV systolic function and hemodynamics in N and CD dogs after ganglionic blockade are reported in Table 3 . Except for a decrease in LV wall thickening and thickening fraction in CD dogs, baseline variables were similar at 4 and 8 weeks for each group. CD dogs consistently differed from N dogs with respect to LV short-axis shortening fraction and heart rate. LV shortaxis shortening and peak LV systolic pressure differed in N and CD dogs, but statistical significance was not reached at all times. LV end-systolic pressure, LV dP/dt, Vcf, LV long-axis shortening and shortening fraction, LV wall thickening and thickening fraction, ejection time, average LV systolic wall stress, and ejection fraction did not differ in N and CD dogs.
Baseline LV end-diastolic hemodynamics and dimensions in N and CD dogs after ganglionic blockade are reported in Table 4 . Both N and CD dogs showed a tendency for a decrease in baseline LV end-diastolic pressure between 4 and 8 weeks, but statistical signifi- tDifferent from normal at p<0.01.
cance was only reached in N dogs. A significant increase in baseline LV end-diastolic wall thickness between 4 and 8 weeks was found in CD dogs. LV end-diastolic wall stress decreased in N dogs between 4 and 8 weeks. However, for all variables considered, N and CD dogs did not differ. Hemodynamic responses to angiotensin II were similar in N and CD dogs at 4 weeks. In N and CD dogs, peak LV systolic pressure increased to 181 1 and 181 + 1 mm Hg, respectively, LV end-systolic pressure increased to 166+1 and 169±2 mm Hg, and LV end-diastolic pressure increased to 15.9+1.5 and 16.8+1.5 mm Hg. LV dP/dt fell to 2,760+80 mm Hg/sec in N dogs and to 2,504-+-117 mm Hg/sec in CD dogs, and stroke volume fell to 14.3+1.5 and to 13.2±1.7 ml, respectively. Heart rate did not change from baseline and averaged 119+6 and 100±5 beats per minute in N and CD dogs, respectively. Hemodynamic responses were similar at 8 weeks in N and CD dogs. Figures 7 and 8 summarize the effects of increases in LV afterload with angiotensin II after ganglionic blockade on the relations of LV short-axis shortening and shortening fraction, Vcf, and ejection fraction to average LV systolic wall stress in N and CD dogs at 4 weeks (Figure 7 ) and at 8 weeks (Figure 8 ). At 4 weeks, differences in LV function between N and CD dogs were abolished. At 8 weeks, only the relation of LV short-axis shortening to average LV systolic wall stress was statistically significant.
Discussion The present study demonstrates that cardiac denervation has significant influence on overall LV function in conscious dogs. Two weeks after cardiac denervation, LV function was depressed and did not improve over an 8-week period. Differences in LV loading conditions were not responsible for this phenomenon. Over a wide range of afterload, relations of LV short-axis shortening and shortening fraction, Vcf, and ejection fraction to average LV systolic wall stress were consistently shifted downward in CD dogs. Therefore, LV contractile state was reduced after cardiac denervation. This altered LV function can be accounted for by the loss of neural influences to the heart because ganglionic blockade abolished differences in LV function between N and CD dogs.
The consequences of cardiac denervation on LV function have been considered earlier. Most prior studies conducted in conscious animals did not report significant differences in global indexes of LV function such as peak systolic and end-diastolic pressures, LV dP/dt, or stroke volume between N and CD dogs.1-8 A direct evaluation of overall LV function in conscious dogs was made by Stinson et al.9 In that study, CD dogs had a reduced LV short-axis shortening fraction compared with N dogs. However, excitement of the dogs included in that study may have influenced measurements of LV function to a significant extent; baseline heart rate averaged 128±10 beats per minute in their N dogs and was paradoxically higher in their CD dogs, averaging 140±5 beats per minute. Studies conducted in conscious animals in which regional ventricular function was measured reported opposite findings. Jones et a13 found that segmental ventricular function was depressed at 2 weeks after sympathectomy and gradually returned toward control levels over an 8-week period. In contrast, Shen et at8 reported that baseline regional wall thickening was similar in N dogs and ventricular denervated dogs and stable over an 8-week period. Consistent with this finding, Amano et a14 did not find differences in segmental ventricular function in N and CD dogs. The reason for the difference in these studies is not apparent, but variations in the position of the crystals in relation to myocardial fiber orientation, in particular for the measurements of segmental function, may increase the variability of the measurements and complicate the comparison of regional ventricular function in different groups of animals.18 '19 The focus of the present study was the investigation of the time course of overall LV function over an 8-week period, which had not been considered earlier. Over this period of observation, LV short-axis shortening and shortening fraction, Vcf, and ejection fraction were consistently reduced in CD dogs, indicating a reduced contractile state in these animals. The stability of these indexes of ventricular function at 2, 4, and 8 weeks after cardiac denervation demonstrates that contractile function of the denervated heart rapidly reaches a steady-state level without any significant improvement over the next 2 months. Ventricular loading conditions did not account for a reduced ventricular function in CD dogs. Peak LV systolic pressure, end-systolic pressure, and average LV systolic wall stress were stable over time and similar in N and CD dogs. Therefore, differences in ventricular afterload were not responsible for the reduction in baseline LV function in CD dogs.
-- It is well accepted that in isolated papillary muscles an increase in afterload leads to a decrease in the extent of myocardial fiber shortening and the velocity of shortening.20 In the whole heart, an afterload mismatch is said to exist when the LV is unable to maintain a normal stroke volume (or the extent of shortening) against an elevated afterload at a given level of myocardial contractility and a fixed preload.2'-24 In the present study, angiotensin II was administered in such a way that LV function could be examined over stepwise increases of LV afterload. In this situation, LV short-axis shortening and shortening fraction, Vcf, and ejection fraction were inversely related to average LV systolic wall stress, consistent with previous studies.21-24 A major difference between N and CD dogs stands out. Relations of indexes of LV contractile function to afterload (wall stress) followed a parallel pattern in N and CD dogs, groups. However, these relations were consistently shifted downward in CD dogs. Thus, at a given level of ventricular afterload, the denervated heart demonstrates a reduced contractile function. We have also considered end-systolic pressure-volume relations as a load-insensitive method for comparing LV contractile function in N and CD dogs. Neither the slope nor the volume intercept differed in the two groups. These findings highlight the poor sensitivity of end-systolic pressure-volume relations to changes in baseline LV contractile state. 25 An influence of preload on baseline LV function can be excluded. LV end-diastolic pressure, wall stress, and LV end-diastolic short-axis dimensions did not differ in N and CD dogs at 2, 4, and 8 weeks. Preload-dependent effects may influence the relation between LV short-axis shortening and average LV systolic wall stress during angiotensin II administration. In fact, Lee et al13 demonstrated that the descending limb of LV performance curves is not only determined by the level of ventricular afterload achieved with angiotensin II but is also related to an inadequate venous return. At a given level of afterload, stroke volume can be significantly increased with volume loading. In the present study, differences in LV short-axis shortening between N and CD dogs could have resulted from a differential effect of angiotensin II on the venous system, thereby altering the preload. To address this issue, relations of LV short-axis shortening to LV end-diastolic wall stress were compared in N and CD dogs at 2, 4, and 8 weeks. A similar pattern in both FIGURE 5. Graphs showing relations of left ventricular (LV) short-axis shortening and shortening fraction, velocity ofcircumferentialfiber shortening (Vcf), and ejection fraction to average systolic wall stress during angiotensin II administration in normal (solid lines) and cardiac-denervated (broken lines) dogs at 8 weeks after instrumentation. Cardiacdenervated dogs consistently differed from normal dogs, as indicated by p values.
groups was observed, but at a given level of preload or LV end-diastolic wall stress, LV short-axis shortening remained consistently lower in CD dogs. Therefore, differences in preload cannot explain the reduction of LV function in CD dogs. We considered that angiotensin II could have influenced the LV inotropic state through a sympathetically mediated effect, as demonstrated by Farr and Grupp26 in anesthetized dogs. In conscious animals, Heyndrickx et al12 also suggested that angiotensin II had slight positive inotropic effects because LV dP/dt failed to decrease in the face of increases in LV pressure. Downing and Sonnenblick"l reported that angiotensin II at high doses increased myocardial contractility, whereas doses in the range of 0.1-2.0 jug * kgmin-1 END-DIASTOLIC WALL STRESS (g/cm2) FIGURE 6. Graphs showing relations of left ventricular short-axis shortening at 2, 4, and 8 weeks after instrumentation to end-diastolic wall stress in normal (solid lines) and cardiac-denervated (broken lines) dogs. Cardiac-denervated dogs consistently differedfrom normal dogs, as indicated by p values.
had little effect. In the present study, the doses of angiotensin II were about 20 times lower than those reported to have minimal effects on myocardial contractility.11 Therefore, it is reasonable to consider that angiotensin II had trivial effects on myocardial contractility in the present study. With the increase in arterial pressure during angiotensin II administration, reflexes arising from the stimulation of high pressure baroreceptors may have influenced LV contractility in N dogs. Consistent with earlier studies in conscious animals12'3 and in human subjects,27 heart rate failed to decrease during angiotensin II administration in N dogs, suggesting that little reflex influences intervened. Increases in LV afterload with angiotensin II had limited influence on myocardial contractility. In the present study, LV dP/dt fell by less than 10% with the highest dose of angiotensin II in N dogs and by a similar amount in CD dogs. Therefore, a specific contribution of reflex influences on LV contractility were not apparent in N dogs. Had they intervened, a narrowing rather than a widening of differences between left ventricular function in N and CD dogs would have appeared. We considered the possibility that differences in LV contractile function between N and CD dogs should be abolished with ganglionic blockade if the lack of neural input to the heart is responsible for the reduced LV function after cardiac denervation. However, an adaptative process triggered by the loss of neural input to the heart may also contribute to differences in LV function between normal and denervated hearts as suggested by a recent study in which heart rate differed in N and CD dogs under ganglionic blockade.28 Ganglionic blockade suppressed differences in the relations of LV short-axis shortening, shortening fraction, Vcf, and ejection fraction to average LV systolic wall stress at 4 weeks. At 8 weeks, only the relation of LV short-axis shortening to average LV systolic wall stress differed, whereas shortening fraction, Vcf, and ejection fraction were similar in N and CD dogs. Therefore, the depressed LV function in CD dogs was the consequence of a lack of neural input to the heart.
One of the implications of the present study concerns the view that catecholamine supersensitivity could compensate the lack of direct neural input to the heart. 29 Our data indicate that this process may not be sufficient to completely restore baseline LV function after cardiac denervation. This hypothesis is supported by the observation of low baseline circulating catecholamine levels Graphs showing the effects of ganglionic blockade on the relations of left ventricular (LV) short-axis shortening and shorteningfraction, velocity ofcircumferential fiber shortening (Vcf), and ejection fraction to average systolic wall stress during angiotensin II administration in normal (solid lines) and cardiac-denervated (broken lines) dogs at 4 weeks after instrumentation. NS, not statistically significant.
in conscious animals and by the fact that inotropic effects may have a threshold plasma norepinephrine concentration more than five times baseline levels.30 This compensatory mechanism could become more important in a situation in which peripheral sympathetic tone is elevated, such as during exercise. We were concerned that differences in LV short-axis shortening between N and CD dogs were not associated with differences in the extent of wall thickening. This could imply that relations between short-axis shortening and wall thickening differed in N and CD dogs. An analysis of the relations of wall thickening to short-axis shortening created by altering LV afterload revealed similar slopes in N and CD dogs. Therefore, in N and CD dogs a reduction of short-axis shortening should result in a reduction of wall thickening. When groups FIGURE 8. Graphs showing the effects of ganglionic blockade on the relations of left ventricular (LV) short-axis shortening and shorteningfraction, velocity ofcircumferential fiber shortening (Vcf), and ejection fraction to average systolic wall stress during angiotensin II administration in normal (solid lines) and cardiac-denervated (broken lines) dogs at 8 weeks after instrumentation. NS, not statistically significant. Values ofprobability indicate differences between groups.
were considered, wall thickening was not reduced in CD dogs in spite of reduced short-axis shortening. This may be the result of regional variations of ventricular wall thickness and thickening associated with slight differences in the site of thickness measurements as well as slight variations of the extent of LV long-axis shortening. If we predict the extent of LV thickening fraction from LV short-and long-axis dimensions and wall volume (ventricular weight) using an ellipsoidal model of a ventricular chamber having an incompressible wall with a homogeneous thickness, baseline LV thickening fraction at 4 weeks would not significantly differ in N (20.5±+ 1.7%) and CD (17.9+0.9%) dogs. Therefore, slight variations in the geometry of the ventricular chamber along with regional differences in LV wall thickness may explain why our measurements of LV wall thickening did not differ in N and CD dogs. The present findings differ from those of Borow et al,31 who found normal LV systolic function in transplanted human hearts on the basis of end-systolic pressure-dimension relations. Several features of the transplanted heart were not found in animals with denervated hearts. Increases in LV mass, LV end-diastolic wall thickness, and reduced LV end-diastolic dimension and volume were all specific to cardiac transplantation. The interpretation of this data is complicated by the fact that LV end-diastolic pressure was not measured in that study. In addition, confounding factors such as rejection and its treatment were not accounted for. Therefore, the specific consequences of cardiac denervation on LV function cannot be considered in the clinical setting of heart transplantation in humans.
In conclusion, the present study demonstrates that cardiac denervation results in a significant reduction of baseline LV function without a recovery over an 8-week period. Differences between N and CD dogs persisted over a wide range of ventricular loading conditions. Finally, suppression of autonomic influences with ganglionic blockade in N and CD dogs abolished differences in LV function, consistent with the hypothesis that a lack of neural input to the heart was responsible for the altered LV function after cardiac denervation.
